QU MARKS WORLD PATIENT SAFETY DAY

This article is primarily intended to raise raising global awareness on the importance of patient safety towards improving patient safety in healthcare system and taking action to reduce avoidable harm in health care. In this context, we present the opinions and insight of several Qatar University College of Pharmacy (QU-CPH) experts from the about the importance of patient safety.

Dr Alla El-Awaisi, QU-CPH Assistant Dean for Student Affairs and QU Health Chair of Interprofessional Education Program, commented: “Patient safety has been recognized by the World Health Organization (WHO) as a global health priority and as such health and academic institutions accreditors are constantly seeking evidence of patient safety initiatives in their daily practices and within the different health programs. We at QU Health are working collaboratively to build capacity and equip healthcare students with the competency needed to respond to the current and future needs of the healthcare system in providing high-quality safe care in line with Qatar National Vision 2030. In addition to specific content incorporated within the curricula of the different health programs at Qatar University.”

Dr. Alla added that “We provide students with interprofessional educational opportunities with a focus on patient safety competencies such as the importance of teamwork, communication, and how to recognize, respond to and disclose patient safety incidents. These activities raise the students’ awareness about this important topic and provide them with the needed knowledge, required skills to exhibit the attitude to practice safely upon graduation.”

Professor Derek Stewart, QU-CPH Professor of Clinical Pharmacy and Practice and QU Health Director of Academic Quality, said, “Medication errors are a major public health concern that negatively impact patient safety and health outcomes. These errors are highly prevalent, occurring at any stage of the medication use processes including prescribing, dispensing, medication administration and monitoring. In March 2017, the World Health Organization launched the third global patient safety challenge, ‘Medication without Harm’, aiming to, ‘drive a process of change to reduce patient harm generated by unsafe medication practices and medication errors’. Research being conducted at Qatar University in collaboration with Hamad Medical Corporation has sought to quantify and characterize medication errors, along with the reasons and factors which lead to error. Further interventions are being developed to reduce and eliminate, where possible, these errors. In addition, efforts are underway to make reporting of medication errors more effective and efficient.”

Prof. Ahmed Awaisu, QU-CPH Head Department of Clinical Pharmacy and Practice provided his insight about the role of academia and healthcare organizations in patient and medication safety. He mentioned: “Patient safety is a critical component of healthcare quality and successful healthcare delivery globally. International health organizations, academic and healthcare institutions, and accreditation agencies place patient safety as an important priority to reduce the risk of preventable harms to patients during the provision of healthcare to an adequate minimum. Medication safety is equally an important facet of patient safety. QU-CPH plays a significant role and contributes in building patient and medication safety culture, education, and research in Qatar and beyond. The College has included the World Health Organization (WHO)’s recommended patient safety modules in its undergraduate program curriculum. From community service standpoint, previous public education and outreach events organized by CPH centered on medication safety issues.” Prof. Ahmed further stated that: “Several professors from the College conduct patient/medication safety research projects in close collaboration with practitioners and researchers from other healthcare institutions in Qatar. Research projects areas include, but not restricted to, patient safety culture in hospital and community pharmacies, medication errors, pharmacovigilance, and adverse drug reaction reporting. Professors have obtained both intramural and extramural grants for conducting relevant research in these areas and have published their findings and reputable scientific journals. These efforts and initiatives invested by the QU-CPH are geared toward building a strong patient safety culture, education, and research in the State of Qatar. Patient and medication safety is everyone’s concern; therefore, concerted joint efforts are needed from healthcare professionals, researchers, safety personnel, and patients to build patient safety culture in healthcare institutions and to minimize the burden associated with medical and medication misadventures in Qatar and beyond.” He adds.

Dr. Anas Hamad, Director of Pharmacy at the Qatar’s National Center for Cancer Care and Research (NCCR) and QU-CPH Adjunct Assistant Professor in Clinical pharmacy and Practice talked about the importance of health workers safety. He said, “Healthcare is one of the most hazardous sectors to work at, sometimes more than construction or manufacturing. Healthcare facilities have serious hazards including transferring and lifting patients, needlesticks, chemicals, infections, violence, stress, and others. Healthcare work occurs in an unpredictable environment with a unique culture. Healthcare providers are ethically obliged to “do no harm” for patients. Some may even put their own health and safety at risk to help their patients. Therefore, it is very important to make the physical and psychological safety of staff a first priority for any healthcare organization. This will help in ensuring a better and safer healthcare is being provided for all patients.”

Dr. Anas further stressed on the importance of sustainable quality and patient safety improvement. He adds, “Identifying improvement changes in healthcare is relatively easy. However, the biggest challenge is sustaining improvement efforts over time. A main reason is the failure to make a balance between involving people in the process and getting results quickly. The fact that healthcare organizations must continue to deliver care to patients while simultaneously innovating the way care is delivered can be also a challenge. The most successful healthcare organizations achieve the right balance by securing the three inter-connected pillars of sustainable quality and patient safety improvement; efficient and effective operating system, supportive management infrastructure, and deep-rooted learning organization.

Dr. Monica Zolezzi, QU-CPH Associate Professor of Clinical Pharmacy and Practice, and the Coordinator of the Structured Practice Experiences in Pharmacy (SPEP) Program commented that, “The pharmacist is uniquely trained to be able to impact medication safety at the individual patient level through medication management skills that are part of the clinical pharmacist's role, but also to analyze the performance of medication processes and to lead redesign efforts to mitigate drug-related outcomes that may cause harm. At QU-CPH, the curriculum supports the worldwide implementation of patient safety education. As part of the CPH experiential education program at QU, we partner with our colleagues in practice to expose our students to various practice settings where they gain valuable experience on several aspects of medication safety, along with interpersonal and project management skills, all of which are required to prepare pharmacists to be confident medication safety practitioners.”

“Basically, all the assignments that students complete during their undergraduate experiential education program address different aspects of medication safety. One of these, the “SWOT Analysis Assignment” (an acronym for: Strengths, Weaknesses, Opportunities, and Threats) was highlighted last year by students and preceptors as an innovate way for the student to understand and identify the potential medication-related risks within their practice setting, to reflect on them, and to develop an improvement plan or strategy to overcome the barriers to risk reduction. This is just an example of the commitment of QU-CPH to support a culture that emphasizes in patient-centered care to prepare future pharmacists to prioritize and implement patient safety when in practice.” she added.

Dr Daoud Al-Badriyeh, QU-CPH Associate Professor of Health Economics and Outcome Research, narrated, “A young woman died from an overdose during chemotherapy. A man had a wrong leg amputated. A nine years old boy died during a ‘minor’ surgery due to a drug mix-up. While such horrible cases can make headlines in media, they are only a tiny part of a much bigger problem. In the USA, medical errors are shockingly the third-leading cause of death in the population, preceded by cardiovascular disease and cancer only. While errors also have a monetary burden to them, given the increased resource utilization, not all costs are directly measured. Patients show loss of trust in the system, and health care providers show loss of self-esteem and frustration. Society overall also experiences lost productivity and lower health status. All of this while keeping in mind that only less than 10% of errors are anticipated to be known and are reported”. Dr Daoud added: “While the need to enhance patient safety is acknowledged, the real difficulty is that decision-makers have been looking at patient safety as a standalone problem. There is really no single solution to this. No standalone actions to improve safety can be found. Newer strategies that are based on ‘combined’ efforts and goals are needed at many of the different aspects of practices; from improving the provider-patient partnership, the electronic systems for error monitoring, the standards of health IT, and the collaborative research agendas, to addressing the massive gaps in knowledge, to the need of the stakeholders, regulatory organizations and insurance companies to motivate error reduction and enhance competencies.”

Dr Daoud elaborated, “In Qatar, there is clearly room for much effort and relevant studies. Within the context of pharmacy, here in the College of Pharmacy, Qatar University, I am currently leading several funded initiatives in collaboration with Hamad Medical Corporation that are underway to analyze the reported medication-related errors in the different hospitals and their consequences, including the strategies adopted and the generated cost savings.”

“Overall, the problem of errors is very complex, and it may still take us several decades for our health systems to be truly safe. In Qatar at least, there is clearly room for much effort and relevant studies.” He further added.

Source: Qatar University

His Highness Sheikh Mohamed bin Zayed calls Brazilian President to check on his health

His Highness Sheikh Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, today called Jair Bolsonaro, President of Brazil, over the phone, to check on his health while wishing him a speedy recovery and wellbeing.

His Highness Sheikh Mohamed bin Zayed also conveyed to President Bolsonaro, who was recently hospitalised, the best wishes of President His Highness Sheikh Khalifa bin Zayed Al Nahyan, who wished him good health and further development and prosperity to the Brazilian people.

Bolsonaro thanked His Highness Sheikh Mohamed for his kindness, and wished the UAE and its people ongoing prosperity and development.

Source: Ministry of Foreign Affairs & International Cooperation

Third Shipment of Qatari Medical Aid Arrives in Paraguay

The third shipment of medical aid (Moderna's COVID-19 vaccines) provided from the State of Qatar to the Republic of Paraguay, arrived today in Asuncion International Airport.

Attending the delivery of the aid was HE Minister of Foreign Relations of the Republic of Paraguay Euclides Acevedo, HE Strategic Affairs Advisor at the Presidency Federico Gonzalez, HE Deputy Minister of Health and Social Welfare of the Republic of Paraguay Lida Sosa, HE Ambassador of Paraguay to the State of Qatar Angel Barchini, and HE Acting Charges D'affaires at the Embassy of the State of Qatar to Paraguay Said bin Hamad Al Marri.

HE the Minister of Foreign Relations expressed his thanks to the State of Qatar's government and people for their donations and solidarity with the Paraguayan people in difficult times. His Excellency praised the strength of bilateral ties between the two countries and their leadership, stressing that the Paraguayan people will not forget the aid.

For his part, HE Strategic Affairs Advisor at the Presidency expressed his thanks to the State of Qatar's government and people for the aid that arrived at a time when Paraguay is facing a severe crisis, praising bilateral ties.

The Deputy Minister of Health and Social Welfare of the Republic of Paraguay meanwhile expressed her thanks to the State of Qatar's government and people and praised ties between the two countries.

For his part, HE Acting Charges D'affaires at the Embassy of the State of Qatar to Paraguay praised bilateral ties and stressed that the State of Qatar always rushes to aid friendly countries. He added that the aid reflects the strong relations between the two countries.

Source: Ministry of Foreign Affairs

UAE sends 100,000 COVID-19 vaccine doses to Philippines

The UAE dispatched an aircraft, which arrived in the Philippines' capital of Manila today, carrying medical supplies, including 100,000 COVID-19 vaccine doses, as part of the UAE's ongoing efforts to support countries in containing the COVID-19 pandemic.

Khaled Al Hajri, Chargé d'Affaires at the UAE Embassy in Manila, said that this step aligns with the UAE leadership's keenness to support efforts made by authorities in the Philippines to curb the spread of the COVID-19 pandemic.

He noted that the Philippines was among the first countries to receive medical aid from the UAE, wherein the UAE sent an aircraft carrying 7.3 metric tonnes of medical supplies in April 2020.

Al Hajri highlighted the deep ties between the UAE and the Philippines, which span several decades.

Since the pandemic's onset, the UAE has provided more than 2,250 metric tonnes of aid to more than 136 countries.

Source: Ministry of Foreign Affairs & International Cooperation

UAE sends 500,000 COVID-19 vaccine doses to Tunisia

The UAE has dispatched an aircraft carrying 500,000 doses of the COVID-19 vaccine to Tunisia to curb the spread of the virus.

This urgent response comes in line with the directives of His Highness Sheikh Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, to enhance the health conditions of the Tunisian people during the pandemic.

Rashid Mohammed Al Mansouri, UAE Ambassador to Tunisia, stated that the leadership’s directives to send the COVID-19 vaccine doses are in line with the UAE’s support for the Tunisian people during the difficult circumstances Tunisia is facing now as a result of the pandemic.

He added that in November 2020, the UAE sent a plane to Tunisia carrying 11 tonnes of medical diagnostic equipment, ventilators, mobile breathing units and PPE (personal protective equipment) to enhance the efforts of frontline workers.

Earlier this week, His Highness Sheikh Mohamed bin Zayed received a phone call from President Kais Saied of Tunisia, wherein they discussed the latest developments of COVID-19 and its health, humanitarian and social impacts.

Source: Ministry of Foreign Affairs & International Cooperation

UAE sends new batch of COVID-19 vaccine doses to Sudan

The UAE today dispatched an aircraft carrying 30,000 doses of the COVID-19 vaccine to Sudan to support its efforts to curb the spread of the pandemic.

The aircraft was received at Khartoum International Airport by Hamad Mohammed Humaid Al Junaibi, UAE Ambassador to Sudan, Dr Omar Al-Najeeb, Federal Minister of Health, several officials from the Ministry of Health, and members of the UAE diplomatic mission.

"The UAE and Sudan share profound and historic ties. The UAE will always support Sudan and its people under all circumstances," Al Junaibi said, adding that the UAE's aid to Sudan totalled 100 tonnes to date, which is part of the country’s efforts to address the COVID-19 pandemic.

The UAE has provided nearly 1,800 tonnes of medical supplies to 135 countries, supporting over 1.8 million healthcare workers in the battle against COVID-19, Al Junaibi noted.

Al Najeeb thanked the UAE for its continuous support for Sudan, highlighting the gratitude of the Sudanese people to the UAE’s government and people for their continuous support, particularly in the medical field.

"Since February 2021, the UAE has dispatched many COVID-19 vaccine shipments, underscoring its keenness to support Sudan in containing the pandemic," he said.

Source: Ministry of Foreign Affairs & International Cooperation

Qatar Stresses COVID-19 Social and Economic Impacts to Affect Progress in Achieving Sustainable Development Goals

The State of Qatar underlined that the COVID-19 pandemic poses an unprecedented threat to countries and societies, and its repercussions, especially the economic and social, will affect the progress made towards achieving the sustainable development goals and the protection and promotion of human rights.

This came in the statement of the State of Qatar, delivered by HE Permanent Representative of the State of Qatar in Geneva Ambassador Ali Khalfan Al Mansouri, before the Human Rights Council during the interactive dialogue on the High Commissioners report on the central role of the State in responding to pandemics and other health emergencies and the social and economic consequences thereof.

HE Qatar's Permanent Representative stressed the need of adopting a joint international cooperative approach in order to ensure an effective and coordinated response to limit the negative impacts imposed by the coronavirus pandemic, and to ensure that vaccines are accessible to everyone in a safe, urgent and equitable manner.

Since the start of the pandemic, the State of Qatar has been keen on providing all services, health and medical care and vaccination to all citizens and residents, HE Ambassador Al Mansouri said, stressing that the issue of protecting and respecting human rights was the basis for the measures taken to protect from the virus and address its repercussions.

HE Qatar's Permanent Representative in Geneva added that the State of Qatar has also provided the necessary support to reduce the negative effects, especially the economic and the social, and has adopted many measures to ensure the full protection of expat workers and that they obtain all their rights.

HE Ambassador Al Mansouri noted that the State of Qatar provided medical assistance to nearly 88 countries, in addition to government and non-government assistance amounted to more than $256 million. The State also supported programs for the development and provision of vaccines, and allocated a large part of development aid to developing and the least developing countries aiming at enhancing their capabilities for facing challenges, resilience and recovery.

Source: Ministry of Foreign Affairs

SUCCESS OF THE RECENT COVID-19 SPECIAL ISSUE ORGANIZED IN EMMA JOURNAL

Emergent Materials (EMMA) is a materials science journal established by Qatar University under Springer. Since its foundation in 2018, Emergent Materials aimed to focus on evolving techniques/technologies for advanced materials in a wide variety of fields such as polymer science, renewable energy, water desalination, composites, high tech devices, membranes, nanotechnology and biomaterials. The journal founding chief editor is our VP for Research and Graduate Studies, Prof. Mariam Al-Madeed, who has also Materials Science background. Other chief editors are, Prof. Karim Alamgir, a renowned researcher in the field from University of Houston and Assoc. Prof. Huseyin Yalcin from QU Biomedical Research Center. The journal has been steadily increasing its quality and impact in the field by publishing high quality research papers and as a result, it was recently being accepted to be indexed in Scopus and Web of Science.

Latest issue of the journal is published in February of this year and is a Special Issue dedicated to Covid-19 related applications. The Covid-19 pandemic, associated with SARS-CoV-2 infection transmitted via human to human and cause life-threatening respiratory diseases, has emerged as an ever-increasing global health and economic crisis since its declaration by The World Health Organization (WHO) in early Jan 2020. Despite the development of several vaccines and initiation of vaccination programs, it is very likely that we will have to continue our lives under now became normal preventative measures for several more years. As a nation constantly promoting science and R&D, Qatar responded to the pandemic with the quickly established relevant support programs for the pandemic situation. In this unprecedented scenario, researchers in Qatar and in other countries are seeking fast, practical, and effective ways to support healthcare providers in treating patients and prevent or slow further spread of the virus. In this dazzling race against time, materials science is one of the fields that is contributing significantly, due to a substantial cumulative knowledge that can be translated rapidly to clinical practice. Novel material approaches of tunable performance can be useful for various multi-tasking applications such as accurate diagnosis of viral infection from patient samples, sanitizing or preventing viral accumulation on surfaces, alternative sources and sanitation for personal protective equipment, effective delivery and binding of antiviral agents to the virus, reprogramming of the immune system, and even development of injectable synthetic compounds to compete with the virus in binding to viral receptors. As EMMA, we aimed to support science in these harsh circumstances since we believe the newly accumulated materials science knowledge needs to be communicated effectively with other talented and courageous minds to win the battle against the pandemic. With above-mentioned into consideration, a special issue was organized in the journal for exploring aspects of novel material science applications to manage Covid-19 pandemic effectively and this timely issue was entitled as “Materials Science in the Battle against Covid-19”.

Dr. Huseyin Yalcin, Research Associate Professor - Biomedical Research Center led the task of organizing the issue, being the Editor in Charge for this special issue. Other co-editors were Dr. Kaitlyn Sadtler, from National Institutes of Health, USA, Dr. from Georgia Institute of Technology, USA, and Dr. Aboubakr M. Abdullah Ali, from QU Center for Advanced Materials. The EMMA COVID-19 Special issue is representative collection of reviews and original papers that would cover and highlight major relevant themes in the field of Materials Science, such as nanomedicine/nanoparticles, bio-sensors, personnel protective equipment, additive manufacturing, medical devices, and biomaterials/tissue engineering. We encourage the whole research community to look into the total of 22 high quality articles from renowned research groups around the globe. We believe these high-quality peer-reviewed articles would introduce the community with urgently required emerging approaches needed for developing novel functional materials strategies to fight with Covid-19 pandemic with the guaranty of success.

The issue includes several perspective/review papers explaining potential impact of material science field for advancement of therapies, diagnostics, and preventative strategies from different perspectives. Edirisinghe and co-workers explain the importance of incorporation of novel biomaterials within “smart” face masks for prevention of transmission and enhancement of antiviral activity. Authors also emphasized environmentally acceptable material selection to minimize long-lasting effect on the environment. Bencherif and co-workers elegantly summarized emerging approaches used in the development of new therapies, such as virus deactivating surface coatings, biomaterials used for 2D/3D cell culture as drug screening models, organ on a chip technologies, and biomaterials for targeted antiviral drug delivery systems. While Mozafari and co-workers presented a general overview for the use of different nano-enabled biomaterial based approaches for addressing current pandemic as well as future pandemics, Ashammakhi and co-workers explained more specific applications such as tissue engineering/stem cell technologies, organoids and organ on a chip systems for advancing therapies, drug delivery approaches and vaccines against SARS-COV-2

Nanomedicine is one of the most promising field to advance therapy of this infection, prescribed therapy assessment, and diagnostics of the disease. Special issue has several papers on relevant nano technology approaches. Being an active researcher as well as a clinician, Chakravarthy and co-workers elegantly summarized how the medical field would benefit from nanotechnology for the treatment and diagnosis of Covid-19 pandemic.

The recent SARS-COV-2 outbreak once again reminded us the importance of rapid and direct detection of respiratory disease viruses. Conventional methods for virus detection such as PCR tests are based on techniques relying on cell culture, antigen-antibody interactions, and nucleic acids, which require trained personnel as well as expensive equipment. Microfluidic technologies, on the other hand, can accurately detect respiratory tract viruses with high specificity. We included several papers in the special issue explaining novel biosensor technologies for enhanced diagnostics of SARS-COV-2. Tekin and co-workers summarized a variety of microfluidic-based virus detection methods for respiratory diseases and explained potential impacts of these techniques for the current pandemic by comparison with conventional diagnostic tools currently in use. Inci and co-workers elegantly explained different nanomaterials being used in diagnostic microfluidic platforms currently being developed for COVID-19. Trabzon and co-workers explained high affinity biosensors developed with quantum dots and how this novel technology can be applied for SARS-COV-2 detection in microfluidic systems. Yuce and co-workers presented different viral sensing approaches in microfluidic systems such as plasmonic biosensors, electrochemical biosensors and magnetic biosensors focusing on application to SARS-COV-2 protein detection.

Finally, the issue presents several papers on other novel material science applications relevant to the pandemic such as new medical devices, tissue engineering and additive manufacturing. Mechanical ventilators are widely used in intensive care units for treating Covid-19 patients. These invasive therapies sometimes further injure infected lungs. Prof. Mohammed Chowdhury from Qatar University and co-workers explored different materials to enclose the patient for negative pressure ventilators that are less invasive and suitable for pandemic situations. Ustundag and co-workers summarized major organs that is affected from SARS-COV-2 and different tissue engineering approaches to mitigate the effects of virulence. Huri and co-workers presented novel additive manufacturing applications for prevention of spread of the virus such as production of face masks, face shields, snorkels, as well as production of medical device parts in high demand with this approach.

In each published article of this special issue, there is a novel contribution of production and utilization of biomaterials for biomedical applications relevant to Covid-19. We encourage research community to follow EMMA as reader and contribute their relevant studies in the future.

Source: QATAR UNIVERSITY